Drug Type Small molecule drug |
Synonyms- |
Target |
Action degraders |
Mechanism VAV1 degraders(vav guanine nucleotide exchange factor 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 05 Mar 2026 | |
| Autoimmune Diseases | Discovery | - | 05 Mar 2026 | |
| Neoplasms | Discovery | - | 05 Mar 2026 | |
| Neoplasms | Discovery | - | 05 Mar 2026 |





